2003
DOI: 10.1007/s10295-003-0073-x
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic engineering of Escherichia coli for improved 6-deoxyerythronolide B production

Abstract: Escherichia coli is an attractive candidate as a host for polyketide production and has been engineered to produce the erythromycin precursor polyketide 6-deoxyerythronolide B (6dEB). In order to identify and optimize parameters that affect polyketide production in engineered E. coli, we first investigated the supply of the extender unit ( 2S)-methylmalonyl-CoA via three independent pathways. Expression of the Streptomyces coelicolor malonyl/methylmalonyl-CoA ligase ( matB) pathway in E. coli together with met… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
120
1

Year Published

2003
2003
2017
2017

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 128 publications
(129 citation statements)
references
References 22 publications
3
120
1
Order By: Relevance
“…5 and Table 3). Propionate can be converted to propionyl-CoA and subsequently to (2S)-methylmalonyl-CoA by endogenous propionate-CoA synthetase and propionyl-CoA carboxylase (20). Thus, intact incorporation of propionate into the polyketide backbone is indicative of a methylmalonyl-CoA origin.…”
Section: Gene Inactivation Of Galb -C and -D And The Identificationmentioning
confidence: 99%
“…5 and Table 3). Propionate can be converted to propionyl-CoA and subsequently to (2S)-methylmalonyl-CoA by endogenous propionate-CoA synthetase and propionyl-CoA carboxylase (20). Thus, intact incorporation of propionate into the polyketide backbone is indicative of a methylmalonyl-CoA origin.…”
Section: Gene Inactivation Of Galb -C and -D And The Identificationmentioning
confidence: 99%
“…Presently, although the molecular genetic tools have been developed for most of the important antibiotic-producing organisms and much useful information has been gained describing the genetic control of antibiotic biosynthesis, the application of this new technology to strain improvement of secondary metabolites has met with limited commercial success. Nevertheless, many new innovative approaches towards secondary metabolite strain improvement are now available or under development using a variety of different approaches, some of which show promise for general commercial application to the field (Askenazi et al, 2003;Tang et al, 2000;Murli et al, 2003;Zhang et al, 2002;Lum et al, 2004, Brunker et al, 1998.…”
Section: Introductionmentioning
confidence: 99%
“…Samples of the supernatants were analysed by online extraction by LC-MS. For LC-MS analyses, 20 ml clarified broth was chromatographed on a Phenomenex Develosil column (5 mm, 4?66150 mm) with a mobile phase of 39 % 3 : 2 (v/v) MeCN 15-nor-6-deoxyerythromycin B: Co-expression of ery-ORF5 TEII and eryA DEBS genes in E. coli. The E. coli K207-3 host strain for 6dEB production has been described previously (Murli et al, 2003). Briefly, this strain has four T7-promoter-regulated genes integrated in the chromosome: sfp (required to pantetheinylate the DEBS proteins), prpE (required to convert propionate to propionyl-CoA) and accA1/pccB [required to convert propionyl-CoA to (2S)-methylmalonyl-CoA)].…”
mentioning
confidence: 99%